Digitizing Clinical Trials for Respiratory Research
The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to improved patient experience through the use of wearables and patient apps.

Proven success in complex respiratory research
With over 16,000 patients enrolled across 1,400+ sites, Alcedis brings hands-on experience from medical device studies, post-market trials, and real-world evidence programs in respiratory care. Our reach spans national and multinational studies—from DACH-region trials to global programs involving up to 19 countries.

Global Reach
Multinational respiratory trials conducted across multiple countries with harmonized digital infrastructure

Versatile Study Types
Experience in medical device, post-market, PASS, and prospective RWE programs.

Site Network
More than 1,400 activated sites and over 16,000 enrolled patients across multiple global study setups.
Trust in our Experience
- We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
- Bringing a high level of academic engagement to deliver the full suite of trial-related services, unlike any traditional contract model.

Suitable Technologies
With our strong technological expertise, we are setting new standards in respiratory research with our integrated, patient-centered and data-driven platform.
Discover Technologies
Let's create an impact. Together.
With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of respiratory medicine.
Contact us